Breaking News Instant updates and real-time market news.

REED

Reed's

$4.10

0.07 (1.74%)

, ENZ

Enzo Biochem

$5.07

-0.02 (-0.39%)

17:37
10/13/16
10/13
17:37
10/13/16
17:37

On The Fly: After Hours Movers

UP AFTER EARNINGS: Reed's (REED), up 9.8%... Enzo Biochem (ENZ), up 6.5%. ALSO HIGHER: Zumiez (ZUMZ), up 3.2% after the stock was upgraded to Overweight from Neutral at Piper Jaffray... Scorpio Bulkers (SALT), up 2.9% after the company president disclosed the purchase of 30,000 common shares of the company at an average price of $3.78... Under Armour (UA), up 2% after the stock was upgraded to Overweight from Neutral at Piper Jaffray. LOWER: Smith Micro (SMSI), down 20.8% after the company reported lower than expected preliminary third quarter revenue... Aerohive Networks (HIVE), down 16.5% after the company cut its Q3 guidance and provided guidance for the fourth quarter... Natural Health Trends (NHTC), down 14.1% after the company reported preliminary Q3 revenue... Landmark Infrastructure (LMRK), down 5.3% after the company filed to sell 3M common units for limited partners.

REED

Reed's

$4.10

0.07 (1.74%)

ENZ

Enzo Biochem

$5.07

-0.02 (-0.39%)

ZUMZ

Zumiez

$21.90

-0.57 (-2.54%)

SALT

Scorpio Bulkers

$3.79

0.01 (0.26%)

UA

Under Armour

$38.18

-0.34 (-0.88%)

SMSI

Smith Micro

$2.21

0.02 (0.91%)

HIVE

Aerohive

$5.63

-0.13 (-2.26%)

NHTC

Natural Health Trends

$27.19

-0.865 (-3.08%)

LMRK

Landmark Infrastructure

$17.15

-0.2 (-1.15%)

  • 13

    Oct

  • 14

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 16

    Nov

  • 14

    Oct

REED Reed's
$4.10

0.07 (1.74%)

03/22/16
WDLK
03/22/16
INITIATION
Target $10
WDLK
Buy
Reed's initiated with a Buy at Wunderlich
Wunderlich analyst Mitchell Pinheiro started Reed's with a Buy rating and $10 price target.
ENZ Enzo Biochem
$5.07

-0.02 (-0.39%)

ZUMZ Zumiez
$21.90

-0.57 (-2.54%)

10/13/16
PIPR
10/13/16
UPGRADE
Target $44
PIPR
Overweight
Under Armour upgraded to Overweight after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Erinn Murphy upgraded Under Armour (UA) to Overweight from Neutral following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The survey findings support on-going traction for Under Armour within footwear and the women's segment, noted Murphy, who raised her price target on the stock to $44 from $40. Based on the survey's results, other analysts at the firm also downgraded Estee Lauder (EL) to Neutral from Overweight and upgraded Zumiez (ZUMZ) to Overweight from Neutral.
10/13/16
PIPR
10/13/16
UPGRADE
Target $28
PIPR
Overweight
Zumiez upgraded to Overweight after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Neely Tamminga upgraded Zumiez to Overweight from Neutral following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The Zumiez brand performed better in this year's survey among upper-income teens than it had last year, noted Tamminga. The analyst raised her price target on Zumiez to $28 from $20.
10/13/16
PIPR
10/13/16
UPGRADE
PIPR
Overweight
Zumiez upgraded to Overweight from Neutral at Piper Jaffray
10/06/16
WBLR
10/06/16
UPGRADE
WBLR
Outperform
Zumiez upgraded to Outperform from Market Perform at William Blair
William Blair analyst Sharon Zackfia upgraded Zumiez to Outperform saying September marked the company's best comp gain since February 2015. B. Riley this morning also upgraded Zumiez.
SALT Scorpio Bulkers
$3.79

0.01 (0.26%)

03/17/16
UBSW
03/17/16
DOWNGRADE
Target $3.5
UBSW
Neutral
Scorpio Bulkers downgraded to Neutral from Buy at UBS
UBS analyst Spiro Dounis downgraded Scorpio Bulkers to Neutral citing the company's "continued dilutive" share offerings. Scorpio may need to offer a large discount to the closing price in order to attract new capital, Dounis tells investors in a research note after the company filed to sell 21M shares. He cut his price target for the stock to $3.50 from $4.
03/21/16
EVER
03/21/16
DOWNGRADE
Target $5.5
EVER
Hold
Scorpio Bulkers downgraded to Hold from Buy at Evercore ISI
Evercore analyst Jonathan Chappell downgraded Scorpio Bulkers to Hold to reflect recent dilution from the $61M equity raise and potential for further dilution in the future. The analyst lowered his price target to $5.50 from $9 on Scorpio Bulkers shares.
08/02/16
GHSC
08/02/16
NO CHANGE
Target $5
GHSC
Buy
Scorpio Bulkers coverage assumed with a Buy at Seaport Global
Seaport Global analyst Magnus Fyhr assumed coverage on Scorpio Bulkers with a Buy and $5 price target.
05/05/16
UBSW
05/05/16
DOWNGRADE
Target $3.5
UBSW
Sell
Scorpio Bulkers downgraded to Sell from Neutral at UBS
UBS analyst Spiro Dounis downgraded Scorpio Bulkers to Sell citing the stock's 33% rally since March 17. While the recent equity offering helped extend Scorpio's runway, a bulker market recovery may still be years away, Dounis tells investors in a research note. He keeps a $3.50 price target for the shares.
UA Under Armour
$38.18

-0.34 (-0.88%)

10/13/16
PIPR
10/13/16
UPGRADE
PIPR
Overweight
Under Armour upgraded to Overweight from Neutral at Piper Jaffray
10/10/16
WELS
10/10/16
UPGRADE
WELS
Outperform
Under Armour upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Tom Nikic upgraded Under Armour to Outperform saying "noise" from the Sports Authority's bankruptcy is fading while distribution expansion could lead to sales reacceleration over the next 12-18 months. The analyst believes Under Armour's growth story is intact heading into 2017 and that its inventory levels are improving. Nikic raised his price target range for the shares to $44-$46 from $38-$42.
10/10/16
10/10/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mylan (MYL) upgraded to Strong Buy from Market Perform at Raymond James with Elliot WIlbur saying the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. 2. Under Armour (UA) upgraded to Outperform from Market Perform at Wells Fargo with analyst Tom Nikic saying "noise" from the Sports Authority's bankruptcy is fading while distribution expansion could lead to sales re-acceleration over the next 12-18 months. 3. Deere (DE) and AGCO (AGCO) were upgraded to Outperform from Market Perform at Wells Fargo. 4. Dow Chemical (DOW) upgraded to Buy from Neutral at UBS with analyst John Roberts saying the merger with DuPont (DD) could gain regulatory approval and that the stock is "now too cheap to ignore." 5. Exelixis (EXEL) upgraded to Overweight from Neutral at Piper Jaffray with analyst Edward Tenthoff saying the data are "good enough" to file a supplemental new drug application and could drive off-label front-line RCC use. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SMSI Smith Micro
$2.21

0.02 (0.91%)

10/19/15
NEED
10/19/15
DOWNGRADE
NEED
Hold
Smith Micro downgraded to Hold from Buy at Needham
10/19/15
10/19/15
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AES Corp. (AES) downgraded to Hold from Buy at Argus... Allete (ALE) downgraded to Hold from Buy at Wunderlich... Associated British Foods (ASBFY) downgraded to Hold from Buy at Berenberg... BorgWarner (BWA) downgraded to Underweight from Overweight at Morgan Stanley... C1 Financial (BNK) downgraded to Market Perform from Outperform at Keefe Bruyette... Cameron (CAM) downgraded to Neutral at Susquehanna... Carpenter Technology (CRS) downgraded to Neutral from Overweight at JPMorgan... CenterPoint Energy (CNP) downgraded to Sell from Neutral at Goldman... Compass Minerals (CMP) downgraded to Sell from Neutral at Monness Crespi... Consolidated Edison (ED) downgraded to Sell from Neutral at Goldman... Diamond Foods (DMND) downgraded to Hold from Buy at BB&T... Ecolab (ECL) downgraded to Hold from Buy at Deutsche Bank... Gazprom (OGZPY) downgraded to Sell from Neutral at Goldman... Grainger (GWW) downgraded to Equal Weight from Overweight at Stephens... Great Plains Energy (GXP) downgraded to Neutral from Buy at Goldman... Intrepid Potash (IPI) downgraded to Underperform from Sector Perform at Scotia... Ixia (XXIA) downgraded to Hold from Buy at Wunderlich... Joy Global (JOY) downgraded to Underweight from Hold at BB&T... Novatek (NOVKY) downgraded to Neutral from Buy at Goldman... Oracle (ORCL) downgraded to Sector Weight from Overweight at Pacific Crest... PPL Corp. (PPL) downgraded to Neutral from Buy at Goldman... Pinnacle West (PNW) downgraded to Sell from Neutral at Goldman... Quanta Services (PWR) downgraded to Accumulate from Buy at Johnson Rice... Seagate (STX) downgraded to Neutral at Susquehanna... Silver Bay Realty (SBY) downgraded to Underperform from Neutral at BofA/Merrill... Smith Micro (SMSI) downgraded to Hold from Buy at Needham... SouFun (SFUN) downgraded to Outperform due to recent share strength at CLSA... Telefonica (TEF) downgraded to Underperform from Neutral at Credit Suisse... Ubiquiti Networks (UBNT) downgraded on solar, wireless outlook at JMP Securities... Urban Outfitters (URBN) downgraded to Hold from Buy at Wunderlich... WD-40 (WDFC) downgraded to Neutral from Buy at B. Riley... Waddell & Reed (WDR) downgraded to Market Perform from Outperform at William Blair... Zafgen (ZFGN) downgraded to Market Perform from Outperform at JMP Securities... Zurich Insurance (ZURVY) downgraded to Equal Weight from Overweight at Barclays.
HIVE Aerohive
$5.63

-0.13 (-2.26%)

06/08/16
WDLK
06/08/16
INITIATION
Target $8
WDLK
Buy
Aerohive initiated with a Buy at Wunderlich
Wunderlich analyst Matthew Robison started Aerohive Networks with a Buy rating and $8 price target.
04/05/16
JMPS
04/05/16
NO CHANGE
JMPS
Aerohive could become acquisition target after Ruckus deal, says JMP Securities
After Brocade (BRCD) agreed to buy Ruckus (RKUS), JMP Securities says that Aerohive (HIVE) is the only remaining publicly traded Wi-Fi vendor in the market. Consequently, the firm thinks that major switching vendors without an in-house Wi-Fi solution, including Juniper (JNPR) and Dell, could look to buy Aerohive. Additionally, the firm thinks that the acquisition of Ruckus "could create some disruption in the market," potentially enabling Aerohive to gain share. JMP keeps a $10 price target and Outperform rating on Aerohive.
01/14/16
JMPS
01/14/16
NO CHANGE
JMPS
Aerohive weakness creates buying opportunity, says JMP Securities
JMP Securities says its checks indicate that Aerohive will report "sold" Q4 results and provide "favorable" guidance. The firm says that the stock is "severely undervalued," and it reiterates a $10 price target and Outperform rating on the shares.
11/19/15
JMPS
11/19/15
NO CHANGE
JMPS
Aerohive sell-off unwarranted, says JMP Securities
After meeting with Aerohive's management, JMP Securities thinks the company "is gaining significant sales momentum." According to JMP, the company is benefiting from Aruba's (ARUN) takeover by HP (HPQ), "strong progress with new technology partners, and a market shift toward cloud-managed Wi-Fi." The firm says that the 14% decline in Aerohive's stock following its results was unjustified and has created a buying opportunity. It keeps a $10 price target and Outperform rating on the shares.
NHTC Natural Health Trends
$27.19

-0.865 (-3.08%)

LMRK Landmark Infrastructure
$17.15

-0.2 (-1.15%)

TODAY'S FREE FLY STORIES

02:50
12/06/16
12/06
02:50
12/06/16
02:50
General news
FX Update: Most dollar pairings remained with Monday's ranges »

FX Update: Most dollar…

JUNO

Juno Therapeutics

$20.42

-0.01 (-0.05%)

23:25
12/05/16
12/05
23:25
12/05/16
23:25
Conference/Events
Juno Therapeutics to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SGEN

Seattle Genetics

$66.26

-0.44 (-0.66%)

22:55
12/05/16
12/05
22:55
12/05/16
22:55
Conference/Events
Seattle Genetics to hold an investor reception »

Management reviews the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

GNMSF

Genmab

$171.98

3.9767 (2.37%)

22:30
12/05/16
12/05
22:30
12/05/16
22:30
Conference/Events
Genmab to hold data review meeting »

Management discusses data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

TGTX

TG Therapeutics

$5.70

0.2 (3.64%)

22:25
12/05/16
12/05
22:25
12/05/16
22:25
Conference/Events
TG Therapeutics to hold an investor and analyst reception »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

RHHBY

Roche

$27.67

0.47 (1.73%)

20:25
12/05/16
12/05
20:25
12/05/16
20:25
Conference/Events
Roche to hold an analyst meeting »

Analyst Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AZO

AutoZone

$776.42

-7.32 (-0.93%)

, HDS

HD Supply

$39.75

0.67 (1.71%)

20:25
12/05/16
12/05
20:25
12/05/16
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

AZO

AutoZone

$776.42

-7.32 (-0.93%)

HDS

HD Supply

$39.75

0.67 (1.71%)

MIK

Michaels

$24.31

0.34 (1.42%)

TOL

Toll Brothers

$30.47

1.15 (3.92%)

BOBE

Bob Evans

$46.77

1.05 (2.30%)

CONN

Conn's

$11.20

0.4 (3.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 06

    Dec

  • 14

    Dec

  • 09

    Jan

GDDY

GoDaddy

$34.74

1.45 (4.36%)

20:14
12/05/16
12/05
20:14
12/05/16
20:14
Hot Stocks
GoDaddy acquires WP Curve »

WP Curve announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$74.99

0.9 (1.21%)

20:10
12/05/16
12/05
20:10
12/05/16
20:10
Earnings
Belden sees FY17 adjusted EPS $5.00-$5.25, consensus $5.23 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SGMO

Sangamo

19:39
12/05/16
12/05
19:39
12/05/16
19:39
Hot Stocks
Sangamo reports preclinical, manufacturing data on SB-525, says IND on track »

Sangamo BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SGEN

Seattle Genetics

$66.26

-0.44 (-0.66%)

, BMY

Bristol-Myers

$55.55

-0.41 (-0.73%)

19:38
12/05/16
12/05
19:38
12/05/16
19:38
Hot Stocks
Seattle Genetics, Bristol-Myers: Data supports ADCETRIS, Opdivo combo »

Seattle Genetics (SGEN)…

SGEN

Seattle Genetics

$66.26

-0.44 (-0.66%)

BMY

Bristol-Myers

$55.55

-0.41 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

LGIH

LGI Homes

$32.34

0.45 (1.41%)

19:36
12/05/16
12/05
19:36
12/05/16
19:36
Hot Stocks
LGI Homes reports November home closings up 28.9% y/y »

LGI Homes announced 321…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$116.56

-1.07 (-0.91%)

19:36
12/05/16
12/05
19:36
12/05/16
19:36
Hot Stocks
Celgene reports analysis of three CC-486 studies »

Celgene announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BLUE

bluebird bio

$72.15

2.4 (3.44%)

19:35
12/05/16
12/05
19:35
12/05/16
19:35
Hot Stocks
bluebird bio provides updates on HSC gene therapy programs »

bluebird bio provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$49.88

-7.09 (-12.45%)

19:33
12/05/16
12/05
19:33
12/05/16
19:33
Hot Stocks
Agios 'encouraged' by durable clinical activity of AG-120 »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$60.25

-0.88 (-1.44%)

19:31
12/05/16
12/05
19:31
12/05/16
19:31
Hot Stocks
Merck: KEYNOTE-087 trial data shows oORR of 69%, CRR of 22.4% »

Merck announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 08

    Mar

TWX

Time Warner

$93.34

-0.46 (-0.49%)

, T

AT&T

$38.63

0.02 (0.05%)

19:29
12/05/16
12/05
19:29
12/05/16
19:29
Periodicals
Time Warner 'struggling to expand' HBO Now, NY Post says »

Time Warner (TWX) is…

TWX

Time Warner

$93.34

-0.46 (-0.49%)

T

AT&T

$38.63

0.02 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

BP

BP

, REPYY

Repsol

$13.88

0.25 (1.83%)

19:18
12/05/16
12/05
19:18
12/05/16
19:18
Periodicals
BP acquires Repsol stake in Indonesia LNG plant, Reuters says »

BP (BP) has purchased…

BP

BP

REPYY

Repsol

$13.88

0.25 (1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOSUF

Fosun

19:12
12/05/16
12/05
19:12
12/05/16
19:12
Hot Stocks
Liberty Mutual to acquire Fosun subsidiary Ironshore for roughly $3B »

Liberty Mutual Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$49.75

-0.06 (-0.12%)

, YHOO

Yahoo

$40.20

0.13 (0.32%)

18:54
12/05/16
12/05
18:54
12/05/16
18:54
Periodicals
AOL CEO 'cautiously optimistic' Verizon-Yahoo deal will go through, WSJ says »

AOL CEO Tim Armstrong…

VZ

Verizon

$49.75

-0.06 (-0.12%)

YHOO

Yahoo

$40.20

0.13 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 24

    Jan

TUWOY

Tullow Oil

$2.06

0.109 (5.58%)

18:46
12/05/16
12/05
18:46
12/05/16
18:46
Downgrade
Tullow Oil rating change  »

Tullow Oil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBNK

Guaranty Bancorp

$22.15

0.75 (3.50%)

18:43
12/05/16
12/05
18:43
12/05/16
18:43
Hot Stocks
Breaking Hot Stocks news story on Guaranty Bancorp »

Castle Creek raises stake…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATKR

Atkore

$20.48

-0.18 (-0.87%)

18:41
12/05/16
12/05
18:41
12/05/16
18:41
Syndicate
Atkore files to sell 8M shares of common stock for holders »

The offering is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$107.42

-0.8 (-0.74%)

18:38
12/05/16
12/05
18:38
12/05/16
18:38
Hot Stocks
United Technologies CEO: No quid pro quo on taxes in Carrier deal with Trump »

Says Carrier agreement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPDN

Professional Diversity Network

$9.75

-0.01 (-0.10%)

18:37
12/05/16
12/05
18:37
12/05/16
18:37
Hot Stocks
Breaking Hot Stocks news story on Professional Diversity Network »

North Star cuts passive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.